Cargando…
Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects
Significant progress has been made in the management of renal cell carcinoma (RCC) during the last few decades. In early stage, localized disease, surgical resection remains the modality of choice, with no therapeutic interventions as options for post-operative therapy other than simple observation...
Autores principales: | Liu, Kenneth G., Gupta, Sorab, Goel, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370043/ https://www.ncbi.nlm.nih.gov/pubmed/28061473 http://dx.doi.org/10.18632/oncotarget.14388 |
Ejemplares similares
-
Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors
por: Aly, Ragia, et al.
Publicado: (2020) -
Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2015) -
Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2016) -
Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions
por: Zarour, Luai R., et al.
Publicado: (2017) -
Surgical management of glaucoma: Evolving paradigms
por: Sharaawy, Tarek, et al.
Publicado: (2011)